Mutual of America Capital Management LLC Purchases 2,696 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mutual of America Capital Management LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.0% during the third quarter, Holdings Channel.com reports. The firm owned 56,349 shares of the company’s stock after acquiring an additional 2,696 shares during the period. Mutual of America Capital Management LLC’s holdings in GE HealthCare Technologies were worth $5,288,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in GEHC. O Shaughnessy Asset Management LLC boosted its holdings in GE HealthCare Technologies by 19.1% in the first quarter. O Shaughnessy Asset Management LLC now owns 16,090 shares of the company’s stock valued at $1,463,000 after acquiring an additional 2,577 shares during the last quarter. Lake Street Advisors Group LLC bought a new position in shares of GE HealthCare Technologies during the first quarter worth about $211,000. Crewe Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the first quarter valued at approximately $98,000. EntryPoint Capital LLC increased its stake in GE HealthCare Technologies by 680.0% in the 1st quarter. EntryPoint Capital LLC now owns 468 shares of the company’s stock valued at $43,000 after buying an additional 408 shares during the last quarter. Finally, CreativeOne Wealth LLC bought a new stake in GE HealthCare Technologies during the first quarter worth about $212,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $84.90 on Thursday. The business has a 50-day moving average of $88.54 and a 200-day moving average of $83.58. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a market capitalization of $38.79 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 2.93 and a beta of 1.24. GE HealthCare Technologies Inc. has a 1 year low of $66.39 and a 1 year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. During the same quarter in the prior year, the firm posted $0.99 earnings per share. The business’s quarterly revenue was up .9% compared to the same quarter last year. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date was Friday, October 18th. GE HealthCare Technologies’s payout ratio is 3.30%.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Stifel Nicolaus increased their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Evercore ISI boosted their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.36.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.